These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 6126664)

  • 1. Water supply aluminium concentration, dialysis dementia, and effect of reverse-osmosis water treatment.
    Davison AM; Walker GS; Oli H; Lewins AM
    Lancet; 1982 Oct; 2(8302):785-7. PubMed ID: 6126664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Water purification and the incidence of fractures in patients receiving home haemodialysis supervised by a single centre: evidence for "safe" upper limit of aluminium in water.
    Platts MM; Owen G; Smith S
    Br Med J (Clin Res Ed); 1984 Mar; 288(6422):969-72. PubMed ID: 6423163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteomalacic dialysis osteodystrophy: Evidence for a water-borne aetiological agent, probably aluminium.
    Ward MK; Feest TG; Ellis HA; Parkinson IS; Kerr DN
    Lancet; 1978 Apr; 1(8069):841-5. PubMed ID: 76795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silicon and aluminium interactions in haemodialysis patients.
    Parry R; Plowman D; Delves HT; Roberts NB; Birchall JD; Bellia JP; Davenport A; Ahmad R; Fahal I; Altmann P
    Nephrol Dial Transplant; 1998 Jul; 13(7):1759-62. PubMed ID: 9681724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma aluminium: a redundant test for patients on dialysis?
    Gault PM; Allen KR; Newton KE
    Ann Clin Biochem; 2005 Jan; 42(Pt 1):51-4. PubMed ID: 15802033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aluminium-related osteomalacia: response to reverse osmosis water treatment.
    Smith GD; Winney RJ; McLean A; Robson JS
    Kidney Int; 1987 Jul; 32(1):96-101. PubMed ID: 3626303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aluminium and fluoride in the water supply and their removal for haemodialysis.
    Cameron AP; Drury PJ; Harston GA; Ineson PR
    Sci Total Environ; 1988 Sep; 76(1):19-28. PubMed ID: 3238412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain-aluminium concentration in dialysis encephalopathy.
    McDermott JR; Smith AI; Ward MK; Parkinson IS; Kerr DN
    Lancet; 1978 Apr; 1(8070):901-4. PubMed ID: 76845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scalp hair as an indicator of aluminium exposure: comparison to bone and plasma.
    Wilhelm M; Passlick J; Busch T; Szydlik M; Ohnesorge FK
    Hum Toxicol; 1989 Jan; 8(1):5-9. PubMed ID: 2785480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dialysate aluminium concentration and renal bone disease.
    Walker GS; Aaron JE; Peacock M; Robinson PJ; Davison AM
    Kidney Int; 1982 Feb; 21(2):411-5. PubMed ID: 7070002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction of microcytosis following elimination of an occult source of aluminum contamination of dialysate.
    Abreo K; Brown ST; Sella M
    Am J Kidney Dis; 1989 Jun; 13(6):465-8. PubMed ID: 2729267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in bone histoquantitative parameters and histochemical staining reactions for aluminium in a group of patients with chronic renal failure following a reduction in the aluminium concentration of the haemodialysis fluid.
    McClure J; Fazzalari NL; Fassett RG; Pugsley PG
    J Clin Pathol; 1984 Jul; 37(7):743-7. PubMed ID: 6747011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum and dialysate aluminium concentration of dialysed patients with chronic renal failure determined by atomic absorption spectrometry with a graphite furnace.
    Mazzeo-Farina A; Cerulli N
    Clin Chim Acta; 1985 Apr; 147(3):247-54. PubMed ID: 3995774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is aluminium a dementing ion?
    Lancet; 1992 Mar; 339(8795):713-4. PubMed ID: 1347589
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hyperaluminemia in chronic hemodialysis patients. Evaluation of the respective roles of dialysate aluminum and oral aluminum hydroxide].
    Tahiri Y; Moriniere P; Jaudon MC; Dkhissi H; Rosa A; Fournier A
    Nephrologie; 1983; 4(3):129-33. PubMed ID: 6633778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aluminium toxicity during regular haemodialysis.
    Elliott HL; Dryburgh F; Fell GS; Sabet S; Macdougall AI
    Br Med J; 1978 Apr; 1(6120):1101-3. PubMed ID: 638617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Composition of the domestic water supply and the incidence of fractures and encephalopathy in patients on home dialysis.
    Platts MM; Goode GC; Hislop JS
    Br Med J; 1977 Sep; 2(6088):657-60. PubMed ID: 902042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of aluminum in dialysis dementia.
    Dunea G; Mahurkar SD; Mamdani B; Smith EC
    Ann Intern Med; 1978 Apr; 88(4):502-4. PubMed ID: 637430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fracturing dialysis osteodystrophy and dialysis encephalopathy. An epidemiological survey.
    Parkinson IS; Ward MK; Feest TG; Fawcett RW; Kerr DN
    Lancet; 1979 Feb; 1(8113):406-9. PubMed ID: 84261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of ion exchange to remove aluminum from water used in hemodialysis.
    Petrie JJ; Fleming R; McKinnon P; Winney RJ; Cowie J
    Am J Kidney Dis; 1984 Jul; 4(1):69-74. PubMed ID: 6741939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.